Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07128069 · ClinicalTrials.gov registry record · NA

Can Vitamin D Reduce the Burden of COVID-19?

A NA study of COVID-19, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
2,093
Enrollment target
1
Study location

NCT07128069 is a NA study of COVID-19 that has completed, run by University of Chicago. The registered enrollment target is 2,093 participants, below the 55,204-participant average among 203 other COVID-19 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07128069, a NA study of COVID-19, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
2,093 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the risks of COVID-19 in individuals from the Chicagoland area and other communities in the United States randomized to low (400 IU/day) versus moderate (4,000 IU/day) dose vitamin D.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Vitamin D 400IU
  • DIETARY_SUPPLEMENT Vitamin D 4000IU

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 2,093 participants
Start Date 2020-12-28
Est. Completion 2025-02-15
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT07128069

The ClinicalTrials.gov registry entry for NCT07128069 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,093 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,204-participant average among 203 other COVID-19 trials with a reported enrollment target (96% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Vitamin D 400IU is the first listed.

NCT07128069 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07128069 about?

NCT07128069 is a clinical study titled "Can Vitamin D Reduce the Burden of COVID-19?". The purpose of this study is to compare the risks of COVID-19 in individuals from the Chicagoland area and other communities in the United States randomized to low (400 IU/day) versus moderate (4,000 IU/day) dose vitamin D.

What is the current status of trial NCT07128069?

This trial is currently completed. It is a NA study. The enrollment target is 2,093 participants. The study started on 2020-12-28. Estimated completion is 2025-02-15.

What conditions does trial NCT07128069 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT07128069?

The interventions under investigation include: Vitamin D 400IU (DIETARY_SUPPLEMENT), Vitamin D 4000IU (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07128069?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07128069 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.